Email this article EKONOMIChESKAYa EFFEKTIVNOST' VAKTsINATsII PROTIV VETRYaNOY OSPY KOGORTY DETEY V VOZRASTE 2 LET V ROSSIYSKOY FEDERATsII
- Authors: Kostinov MP1, Zverev VV1
-
Affiliations:
- Issue: Vol 89, No 3 (2012)
- Pages: 43-50
- Section: Articles
- URL: https://microbiol.crie.ru/jour/article/view/13678
- ID: 13678
Cite item
Full Text
Abstract
Aim. Perform calculation of the economical effectiveness of realization of a program of vaccination
of children aged 2 years against chickenpox (CP) in the Russian Federation. Materials and
methods. Data of Federal service on customers rights protection and human well-being surveillance
on evaluation of morbidity and losses caused by CP in the Russian Federation in 2008 - 2010
were used. A cohort of children (1 760 000) aged 2 years subject to vaccination against CP in 2011,
evaluation of cost of 1 case of the infection, the amount of losses per vaccination of 1 child were
approximately determined; analysis of prevented losses by implementation of vaccination program
by using mathematical modeling methods was performed. Results. Without vaccination program
in the Russian Federation the cost of losses per 1 case of CP related to hospitalization and outpatient
visits as well as temporary disability of one of the parent in various age groups was: for children
aged 1 - 2 years - 8 333 RUB (Russian rubles), 3 - 6 years - 21 171 RUB, 7 - 14 years - 21 295
RUB. The cost of vaccination against CP of 1 child including 2 doses of vaccines with physician
examination and vaccination procedure would be 1600 RUB. In the case of realization of vaccination
program against CP in 2011 of children aged 2 years its cost would be 2 488.9 million RUB.
Cost prevention already exceeds the cost of vaccination in 1 age cohort of children at year 2 and
in 5 years the amount of prevented losses would exceed 15 billion RUB per 1 vaccinated cohort
and would continue to increase steadily. Conclusion. The performed calculations show that vaccination
against CP in the Russian Federation is a highly efficient investment. Self-sufficiency of
a program implemented in 2011 may be obtained already at the start of year 2 after the realization
and by 2016 the net economical benefit would be around 8 milliards RUB.
of children aged 2 years against chickenpox (CP) in the Russian Federation. Materials and
methods. Data of Federal service on customers rights protection and human well-being surveillance
on evaluation of morbidity and losses caused by CP in the Russian Federation in 2008 - 2010
were used. A cohort of children (1 760 000) aged 2 years subject to vaccination against CP in 2011,
evaluation of cost of 1 case of the infection, the amount of losses per vaccination of 1 child were
approximately determined; analysis of prevented losses by implementation of vaccination program
by using mathematical modeling methods was performed. Results. Without vaccination program
in the Russian Federation the cost of losses per 1 case of CP related to hospitalization and outpatient
visits as well as temporary disability of one of the parent in various age groups was: for children
aged 1 - 2 years - 8 333 RUB (Russian rubles), 3 - 6 years - 21 171 RUB, 7 - 14 years - 21 295
RUB. The cost of vaccination against CP of 1 child including 2 doses of vaccines with physician
examination and vaccination procedure would be 1600 RUB. In the case of realization of vaccination
program against CP in 2011 of children aged 2 years its cost would be 2 488.9 million RUB.
Cost prevention already exceeds the cost of vaccination in 1 age cohort of children at year 2 and
in 5 years the amount of prevented losses would exceed 15 billion RUB per 1 vaccinated cohort
and would continue to increase steadily. Conclusion. The performed calculations show that vaccination
against CP in the Russian Federation is a highly efficient investment. Self-sufficiency of
a program implemented in 2011 may be obtained already at the start of year 2 after the realization
and by 2016 the net economical benefit would be around 8 milliards RUB.
References
- Баранов А.А., Балашов Д.Н., Горелов А.В. и др. Предотвращение ветряной оспы средствами специфической профилактики в Беларуси, Казахстане, России и Украине. Педиатрическая фармакология. 2008, 3: 6-14.
- Инфекционная заболеваемость в РФ в 2005-2009 гг. (информационные сборники статистических и аналитических материалов). М., Федеральный ЦГиЭ Роспотребнадзора, 2006-2010.
- Постановление Правительства Москвы от 29.04.2008 № 334-ПП «О территориальной программе государственных гарантий оказания населению города Москвы бесплатной медицинской помощи на 2008 год».
- Ориентировочные сроки временной нетрудоспособности при наиболее распространенных заболеваниях и травмах (в соответствии с МКБ-10) (утв. Минздравом РФ № 2510/9362-34, ФСС РФ № 02-08/10-1977П от 21.08.2000).
- Enders G., Miller E., Cradock-Watson J. et al. Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet. 1994, 343: 1548-1551.
- Galil K., Brown C., Lin F. et al. Hospitalisations for varicella in the United States, 1988 to 1999. Pediatr. Infect. Dis. J. 2002, 21: 931-934.
- Gershon А., Takahashi М., Seward J. Varicella vaccine. In: S. Plotkin et al. (еd.). Vaccines. Philadelphia, PA. 2004, р. 783- 823.
- Gershon A.A. Varicella zoster virus: prospects for control. Adv. Pediatr. Infect. Dis. 1995, 10: 93-124.
- Nathwani D., Maclean A., Conway S. et al. Varicella infections in pregnancy and the newborn. A review prepared for the UK Advisory Group on Chickenpox on behalf of the British Society for the study of infection. J. Infect. 1998, 36 (1): 59-71.
Supplementary files
